Although the pro-inflammatory microenvironment is the hallmark of AML, anti-inflammatory cytokines, such as transforming growth factor beta (TGF-β) and interleukin-10 (IL-10), greatly contribute to the cytokine dysregulation implicated in AML progression and worsening survival (Figure 2) [136]. This evidence concerns the gene IL10 and acute myeloid leukemia.